Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Technologies for localization and diagnosis of prostate cancer
Luleå University of Technology, Department of Computer Science, Electrical and Space Engineering, Signals and Systems.ORCID iD: 0000-0003-3268-1691
2009 (English)In: Journal of Medical Engineering & Technology, ISSN 0309-1902, E-ISSN 1464-522X, Vol. 33, no 8, p. 585-603Article in journal (Refereed) Published
Abstract [en]

The gold standard for detecting prostate cancer (PCa), systematic biopsy, lacks sensitivity as well as grading accuracy. PSA screening leads to over-treatment of many men, and it is unclear whether screening reduces PCa mortality. This review provides an understanding of the difficulties of localizing and diagnosing PCa. It summarizes recent developments of ultrasound (including elastography) and MRI, and discusses some alternative experimental techniques, such as resonance sensor technology and vibrational spectroscopy. A comparison between the different methods is presented. It is concluded that new ultrasound techniques are promising for targeted biopsy procedures, in order to detect more clinically significant cancers while reducing the number of cores. MRI advances are very promising, but MRI remains expensive and MR-guided biopsy is complex. Resonance sensor technology and vibrational spectroscopy have shown promising results in vitro. There is a need for large prospective multicentre trials that unambiguously prove the clinical benefits of these new techniques.

Place, publisher, year, edition, pages
2009. Vol. 33, no 8, p. 585-603
National Category
Other Medical Engineering
Research subject
Medical Engineering for Healthcare; Centre - Centre for Biomedical Engineering and Physics (CMTF)
Identifiers
URN: urn:nbn:se:ltu:diva-4331DOI: 10.3109/03091900903111966PubMedID: 19848851Scopus ID: 2-s2.0-70350492898Local ID: 242c1810-ae80-11de-8293-000ea68e967bOAI: oai:DiVA.org:ltu-4331DiVA, id: diva2:977195
Projects
Prostatacancer
Note

Validerad; 2009; 20091001 (ysko)

Available from: 2016-09-29 Created: 2016-09-29 Last updated: 2024-03-26Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopushttp://informahealthcare.com/doi/abs/10.3109/03091900903111966

Authority records

Candefjord, StefanRamser, KerstinLindahl, Olof

Search in DiVA

By author/editor
Candefjord, StefanRamser, KerstinLindahl, Olof
By organisation
Signals and Systems
In the same journal
Journal of Medical Engineering & Technology
Other Medical Engineering

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 249 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf